Cross-Transmission Prevention Pays Dividends in MRSA Reduction


In France, the proportion of MRSA has been more than 25 percent since 2000. Prevention of hospital-acquired (HA) MRSA spread is based on isolation precautions and antibiotic stewardship. At one institution, before 2000, the infection disease and the infection control teams had failed to reduce HA-MRSA rates.

Chalfine, et al. (2012)  implemented a multifaceted hospital-wide prevention program and measured the effects on HA-MRSA colonization and bacteremia rates between 2000 and 2009. From 2000 to 2003, active screening and decontamination of ICU patients, hospital-wide alcohol based hand rubs (ABHR) use, control of specific classes of antibiotics, compliance audits, and feed-backs to the care providers were successively implemented. The efficacy of the program was assessed by HA-MRSA colonized and bacteremic patient rates per 1000 patient-days in patients hospitalized for more than 24 hours.

Compliance with the isolation practices increased between 2000 and 2009. Consumption of ABHR increased from 6.8 L to 27.5 L per 1000 patient-days. The use of antibiotic defined daily doses (DDD) per 1000 patient-days decreased by 31percent. HA-MRSA colonization decreased by 84  percent from 1.09 to 0.17 per 1000 patient-days and HA-MRSA bacteremia by 93 percent, from 0.15 to 0.01 per 1,000 patient-days (p<10-7 for each rate).
In an area highly endemic for MRSA, the researchers say a multifaceted prevention program allows for sustainable reduction in HA-MRSA bacteremia rates. Their research was published in Antimicribial Resistance and Infection Control.

Reference: Chalfine A, et al. Ten-year decrease of acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteremia at a single institution: the result of a multifaceted program combining cross-transmission prevention and antimicrobial stewardship. Antimicrobial Resistance and Infection Control 2012, 1:18 doi:10.1186/2047-2994-1-18.

Related Videos
Association for the Health Care Environment (Logo used with permission)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
Woman lying in hospital bed (Adobe Stock, unknown)
CDC  (Adobe Stock, unknown)
Deborah Birx, MD
Centers for Disease Control and Prevention  (Adobe Stock, unknown)
CDC (Adobe Stock, unknown)
Inside Track with Infection Control Today
Related Content